ADIPOQ and obesity disorder: In fact, obesity enhances the glycolysis pathway in splenic Th1 and Th17 cells, and adiponectin inhibits glycolysis in both an AMPK-dependent and -independent manner, resulting in the amelioration of inflammation (62).